These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 28606050)

  • 1. Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer.
    Barkat MA; Harshita ; Ahmad J; Khan MA; Beg S; Ahmad FJ
    Curr Drug Targets; 2018; 19(1):70-80. PubMed ID: 28606050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymoquinone, a bioactive component of black caraway seeds, causes G1 phase cell cycle arrest and apoptosis in triple-negative breast cancer cells with mutant p53.
    Sutton KM; Greenshields AL; Hoskin DW
    Nutr Cancer; 2014; 66(3):408-18. PubMed ID: 24579801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.
    Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M
    Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer: Thymoquinone antioxidant/pro-oxidant effect as potential anticancer remedy.
    Mahmoud YK; Abdelrazek HMA
    Biomed Pharmacother; 2019 Jul; 115():108783. PubMed ID: 31060003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
    Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B
    Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer.
    Şakalar Ç; İzgi K; İskender B; Sezen S; Aksu H; Çakır M; Kurt B; Turan A; Canatan H
    Tumour Biol; 2016 Apr; 37(4):4467-77. PubMed ID: 26500095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
    Ünal TD; Hamurcu Z; Delibaşı N; Çınar V; Güler A; Gökçe S; Nurdinov N; Ozpolat B
    Anticancer Agents Med Chem; 2021; 21(3):355-364. PubMed ID: 32767958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic perspectives on cancer chemoprevention/chemotherapeutic effects of thymoquinone.
    Kundu J; Chun KS; Aruoma OI; Kundu JK
    Mutat Res; 2014 Oct; 768():22-34. PubMed ID: 25847385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells.
    Adinew GM; Messeha SS; Taka E; Badisa RB; Antonie LM; Soliman KFA
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanisms of Thymoquinone as Anticancer Agent.
    Alhmied F; Alammar A; Alsultan B; Alshehri M; Pottoo FH
    Comb Chem High Throughput Screen; 2021; 24(10):1644-1653. PubMed ID: 33115388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nigella sativa and Cancer: A Review Focusing on Breast Cancer, Inhibition of Metastasis and Enhancement of Natural Killer Cell Cytotoxicity.
    Korak T; Ergül E; Sazci A
    Curr Pharm Biotechnol; 2020; 21(12):1176-1185. PubMed ID: 32351178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse Screening Bioinformatics Approach to Identify Potential Anti Breast Cancer Targets Using Thymoquinone from Neutraceuticals Black Cumin Oil.
    Sundaravadivelu S; Raj SK; Kumar BS; Arumugamand P; Ragunathan PP
    Anticancer Agents Med Chem; 2019; 19(5):599-609. PubMed ID: 30678630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymoquinone: fifty years of success in the battle against cancer models.
    Schneider-Stock R; Fakhoury IH; Zaki AM; El-Baba CO; Gali-Muhtasib HU
    Drug Discov Today; 2014 Jan; 19(1):18-30. PubMed ID: 24001594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymoquinone Anticancer Effects Through the Upregulation of NRF2 and the Downregulation of PD-L1 in MDA-MB-231 Triple-Negative Breast Cancer Cells.
    Adinew G; Messeha SS; Badisa R; Taka E; Soliman KFA
    FASEB J; 2022 May; 36 Suppl 1():. PubMed ID: 35723877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymoquinone Shows the Diverse Therapeutic Actions by Modulating Multiple Cell Signaling Pathways: Single Drug for Multiple Targets.
    Khan MA; Younus H
    Curr Pharm Biotechnol; 2018; 19(12):934-945. PubMed ID: 30421672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor-α36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells.
    Wang X; Zheng N; Dong J; Wang X; Liu L; Huang J
    J Steroid Biochem Mol Biol; 2017 Jul; 171():318-327. PubMed ID: 28529129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymoquinone Augments Cyclophosphamide-Mediated Inhibition of Cell Proliferation in Breast Cancer Cells.
    Khan A; Aldebasi YH; Alsuhaibani SA; Khan MA
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1153-1160. PubMed ID: 31030489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-cancer properties and mechanisms of action of thymoquinone, the major active ingredient of Nigella sativa.
    Majdalawieh AF; Fayyad MW; Nasrallah GK
    Crit Rev Food Sci Nutr; 2017 Dec; 57(18):3911-3928. PubMed ID: 28140613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of gene expression by thymoquinone conjugated zinc oxide nanoparticles arrested cell cycle, DNA damage and increased apoptosis in triple negative breast cancer cell line MDA-MB-231.
    Sjs B; K K; A P; P H; B SR; S S
    Drug Dev Ind Pharm; 2021 Dec; 47(12):1943-1951. PubMed ID: 35510706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer activities of Nigella sativa (black cumin).
    Khan MA; Chen HC; Tania M; Zhang DZ
    Afr J Tradit Complement Altern Med; 2011; 8(5 Suppl):226-32. PubMed ID: 22754079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.